What more can we learn from DTC ad­ver­tis­ing? FDA's OPDP pro­pos­es new re­search

How do specifics around en­dorse­ments, mech­a­nism of ac­tion and med­ica­tion track­ing in phar­ma­ceu­ti­cal ads im­pact con­sumers? That’s what the FDA’s Of­fice of Pre­scrip­tion Drug Pro­mo­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER